Biomarkers in Lung Cancer

Catherine R. Sears, Peter J. Mazzone

Research output: Contribution to journalReview article

Abstract

Biomarkers that focus on lung cancer risk assessment, detection, prognosis, diagnosis, and personalized treatment are in various stages of development. This article provides an overview of lung cancer biomarker development, focusing on clinical utility and highlighting 2 unmet clinical needs: selection of high-risk patients for lung cancer screening and differentiation of early lung cancer from benign pulmonary nodules. The authors highlight biomarkers under development and those lung cancer screening and nodule management biomarkers post-clinical validation. Finally, trends in lung cancer biomarker development that may improve accuracy and accelerate implementation in practice are discussed.

Original languageEnglish (US)
JournalClinics in Chest Medicine
DOIs
StateAccepted/In press - Jan 1 2020

Fingerprint

Lung Neoplasms
Biomarkers
Tumor Biomarkers
Early Detection of Cancer
Lung
Therapeutics

Keywords

  • Clinical utility
  • Lung cancer screening
  • Lung nodules
  • Next-generation sequencing
  • Radiomics
  • Trial design

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Biomarkers in Lung Cancer. / Sears, Catherine R.; Mazzone, Peter J.

In: Clinics in Chest Medicine, 01.01.2020.

Research output: Contribution to journalReview article

@article{648e8e704d5e4cd4a978463b84cab035,
title = "Biomarkers in Lung Cancer",
abstract = "Biomarkers that focus on lung cancer risk assessment, detection, prognosis, diagnosis, and personalized treatment are in various stages of development. This article provides an overview of lung cancer biomarker development, focusing on clinical utility and highlighting 2 unmet clinical needs: selection of high-risk patients for lung cancer screening and differentiation of early lung cancer from benign pulmonary nodules. The authors highlight biomarkers under development and those lung cancer screening and nodule management biomarkers post-clinical validation. Finally, trends in lung cancer biomarker development that may improve accuracy and accelerate implementation in practice are discussed.",
keywords = "Clinical utility, Lung cancer screening, Lung nodules, Next-generation sequencing, Radiomics, Trial design",
author = "Sears, {Catherine R.} and Mazzone, {Peter J.}",
year = "2020",
month = "1",
day = "1",
doi = "10.1016/j.ccm.2019.10.004",
language = "English (US)",
journal = "Clinics in Chest Medicine",
issn = "0272-5231",
publisher = "W.B. Saunders Ltd",

}

TY - JOUR

T1 - Biomarkers in Lung Cancer

AU - Sears, Catherine R.

AU - Mazzone, Peter J.

PY - 2020/1/1

Y1 - 2020/1/1

N2 - Biomarkers that focus on lung cancer risk assessment, detection, prognosis, diagnosis, and personalized treatment are in various stages of development. This article provides an overview of lung cancer biomarker development, focusing on clinical utility and highlighting 2 unmet clinical needs: selection of high-risk patients for lung cancer screening and differentiation of early lung cancer from benign pulmonary nodules. The authors highlight biomarkers under development and those lung cancer screening and nodule management biomarkers post-clinical validation. Finally, trends in lung cancer biomarker development that may improve accuracy and accelerate implementation in practice are discussed.

AB - Biomarkers that focus on lung cancer risk assessment, detection, prognosis, diagnosis, and personalized treatment are in various stages of development. This article provides an overview of lung cancer biomarker development, focusing on clinical utility and highlighting 2 unmet clinical needs: selection of high-risk patients for lung cancer screening and differentiation of early lung cancer from benign pulmonary nodules. The authors highlight biomarkers under development and those lung cancer screening and nodule management biomarkers post-clinical validation. Finally, trends in lung cancer biomarker development that may improve accuracy and accelerate implementation in practice are discussed.

KW - Clinical utility

KW - Lung cancer screening

KW - Lung nodules

KW - Next-generation sequencing

KW - Radiomics

KW - Trial design

UR - http://www.scopus.com/inward/record.url?scp=85077377378&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85077377378&partnerID=8YFLogxK

U2 - 10.1016/j.ccm.2019.10.004

DO - 10.1016/j.ccm.2019.10.004

M3 - Review article

AN - SCOPUS:85077377378

JO - Clinics in Chest Medicine

JF - Clinics in Chest Medicine

SN - 0272-5231

ER -